HT
ZVRA icon

HAP Trading’s Zevra Therapeutics ZVRA Stock Holding History

HAP Trading’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-11,500
Closed -$2K – 2431
2022
Q1 		$2K Sell
11,500
-5,700
-33% -$36.3K ﹤0.01% 2085
2021
Q4 		$31K Sell
17,200
-4,200
-20% -$37.5K ﹤0.01% 1671
2021
Q3 		$21K Sell
21,400
-29,000
-58% -$292K ﹤0.01% 1796
2021
Q2 		$207K Sell
50,400
-59,800
-54% -$643K 0.01% 998
2021
Q1 		$295K Buy
+110,200
New +$962K 0.02% 647

Other funds holding ZVRA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
RPCONE
Retirement Planning Company of New England Warwick, Rhode Island $278M AUM 38.65% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

HAP Trading's ZVRA Position: Q4 2021 in Review

HAP Trading sold out of Zevra Therapeutics (ZVRA) in Q4 2021, closing a stake of 23,733 shares — an estimated $212K sold.

HAP Trading first reported a position in ZVRA in Q3 2021 and held it in 1 quarter. The position peaked at $221K in Q3 2021. 77 funds tracked by Wall St. Rank hold ZVRA as of Q4 2021.

  • HAP Trading reported no remaining Zevra Therapeutics position as of Q4 2021 after selling out during the quarter.
  • HAP Trading sold 23,733 Zevra Therapeutics shares in Q4 2021, an estimated $212K.
  • HAP Trading first reported a position in Zevra Therapeutics in Q3 2021 and held it in 1 quarter.
  • HAP Trading's Zevra Therapeutics position peaked at $221K in Q3 2021.
  • 77 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q4 2021.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.